Literature DB >> 24376272

α-Hemolysin, not Panton-Valentine leukocidin, impacts rabbit mortality from severe sepsis with methicillin-resistant Staphylococcus aureus osteomyelitis.

Anne-Claude Crémieux1, Azzam Saleh-Mghir, Claire Danel, Florence Couzon, Oana Dumitrescu, Thomas Lilin, Christian Perronne, Jérôme Etienne, Gerard Lina, François Vandenesch.   

Abstract

BACKGROUND: Severe sepsis, combining acute osteomyelitis and lung involvement, has been described increasingly in healthy children with the spread of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).
METHODS: Outcomes (mortality, hematogenous spread, lung and bone involvements) of rabbit osteomyelitis caused by CA-MRSA LAC(WT) USA300 and its Panton-Valentine leukocidin (PVL)- and α-hemolysin (Hla)-negative isogenic derivatives (LACΔpvl and LACΔhla, respectively) were compared.
RESULTS: Three days after inoculation (D3), all LAC(WT)- and LACΔpvl-, and 72% of LACΔhla-infected rabbits had no hematogenous spread and similar lung and bone bacterial densities. LACΔpvl and LACΔhla caused less severe histological lung lesions than LAC(WT) (P ≤ .01). Between D3 and D9, 10 (53%) LAC(WT)-, 11 (55%) LACΔpvl-, but no LACΔhla-infected rabbits (P < .005) died of severe sepsis with disseminated infection. Unlike deceased animals, most LAC(WT), LACΔpvl, and LACΔhla D14 survivors had no hematogenous spread (P < .001). LAC(WT) (88%) caused more bone abscesses than LACΔpvl (0, P = .001) or LACΔhla (30%, P = .01).
CONCLUSION: In this model, both PVL and Hla seemed to be required for early lung involvement via hematogenous spread. Hla, but not PVL, significantly impacted severe sepsis-related mortality. PVL was the predominant factor determining late-stage bone abscesses.

Entities:  

Keywords:  CA-MRSA; Panton-Valentine leukocidin; Staphylococcus aureus; osteomyelitis; rabbit model; severe sepsis; α-hemolysin

Mesh:

Substances:

Year:  2013        PMID: 24376272     DOI: 10.1093/infdis/jit840

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

Review 2.  Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.

Authors:  Trevor L Kane; Katelyn E Carothers; Shaun W Lee
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

Review 3.  Life After USA300: The Rise and Fall of a Superbug.

Authors:  Paul J Planet
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

4.  Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations.

Authors:  Yuling Wu; Xu Liu; Ahmad Akhgar; Jia J Li; Hoyin Mok; Bret R Sellman; Li Yu; Lorin K Roskos; Mark T Esser; Alexey Ruzin
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

5.  Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study.

Authors:  Maria Souli; Felicia Ruffin; Seong-Ho Choi; Lawrence P Park; Shengli Gao; Nicholas Christopoulos Lent; Batu K Sharma-Kuinkel; Joshua T Thaden; Stacey A Maskarinec; Lisa Wanda; Jonathan Hill-Rorie; Bobby Warren; Brenda Hansen; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

Review 6.  Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery.

Authors:  Kenneth L Urish; James E Cassat
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 7.  Innate Immunity to Staphylococcus aureus: Evolving Paradigms in Soft Tissue and Invasive Infections.

Authors:  Stephanie L Brandt; Nicole E Putnam; James E Cassat; C Henrique Serezani
Journal:  J Immunol       Date:  2018-06-15       Impact factor: 5.422

Review 8.  The multifaceted resources and microevolution of the successful human and animal pathogen methicillin-resistant Staphylococcus aureus.

Authors:  Agnes Marie Sá Figueiredo; Fabienne Antunes Ferreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-04-29       Impact factor: 2.743

Review 9.  Staphylococcus aureus Arsenal To Conquer the Lower Respiratory Tract.

Authors:  Mariane Pivard; Karen Moreau; François Vandenesch
Journal:  mSphere       Date:  2021-05-19       Impact factor: 4.389

10.  Molecular Characterization and Antimicrobial Susceptibility of Staphylococcus aureus Isolates from Clinical Infection and Asymptomatic Carriers in Southwest Nigeria.

Authors:  Olayemi O Ayepola; Nurudeen A Olasupo; Louis O Egwari; Karsten Becker; Frieder Schaumburg
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.